Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2024-03-12 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously reported stock option grants due to an employee's resignation. This type of disclosure regarding stock options and capital-related changes falls under the category of regulatory filings for corporate actions that do not fit into specific categories like M&A or dividends, and is best classified as a general regulatory filing.
2024-03-12 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (T&R Biofab) regarding a 'Single Sale/Supply Contract' amendment. It details a change in the contract end date due to a request from the client. Since this is a specific regulatory disclosure regarding a material contract update that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2024-02-16 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (전환가액의 조정) for the company TNR Biofab. It details the change in conversion price due to market price fluctuations, the impact on the number of convertible shares, and the calculation methodology. This falls under capital structure changes related to debt-to-equity instruments, which is best classified as a Capital/Financing Update.
2024-02-05 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership by major shareholders and their special related parties. This document specifically details changes in shareholding, collateral contracts, and lending agreements. According to the provided filing definitions, this falls under 'Major Shareholding Notification' (MRQ).
2024-01-30 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). This type of filing is a regulatory requirement for major shareholders to disclose changes in their ownership, including share pledges or changes in shareholding structure. In the context of the provided categories, this falls under 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2024-01-30 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used to disclose significant changes in share ownership, including collateral agreements and changes in special relationships. This falls under the category of 'Major Shareholding Notification' (MRQ).
2024-01-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.